Krishna Institute of Medical Sciences: Intimation u/r 30-acquistion of upto 51 % stake in Insignia
Krishna Institute of Medical Sciences (KIMS) filed a disclosure titled "Intimation u/r 30-acquistion of upto 51 % stake in Insignia". The company is valued at about ₹29,123 crore.
What happened
Krishna Institute of Medical Sciences (KIMS) filed a disclosure with the exchanges on 6 October 2026 at 07:54 PM titled "Intimation u/r 30-acquistion of upto 51 % stake in Insignia".
Company snapshot
Krishna Institute of Medical Sciences is a small-cap company in the Healthcare sector, with a market value of about ₹29,123 crore.
The stock last traded at ₹693.4, against a 52-week range of ₹575.8–₹858 (19.2% below the high).
Before this filing the shares had moved −2.3% over the month and −10.7% over three months. Average daily turnover over the last 20 sessions was about ₹40.73 crore.
Promoters held 32.50% at the end of Q1 FY27; 10.26% of promoter shares were pledged. Foreign institutions owned 14.74% and domestic institutions 34.43%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 872 | 78.6 | 1.96 |
| Q2 FY26 | 961 | 67.1 | 1.67 |
| Q3 FY26 | 998 | 53.4 | 1.33 |
| Q4 FY26 | 1,075 | 42.5 | 1.06 |
| Q1 FY27 | 1,180 | 41.5 | 1.04 |
What history shows
BCEIE's records show 3 previous m&a filings from the company since May 2026.
Across 131 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +1.0% over five days; 60% of them rose the next day.
Market-wide, 1,975 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Shardul Amarchand Mangaldas advises Krishna Institute of Medical Sciences on ₹600 crore preferential allotment of warrants
- SAM & Co. advises Krishna Institute of Medical Sciences on preferential allotment of warrants aggregating to approximately INR 600 Crore to certain members of its Promoter & Promoter Group
- Krishna Institute of Medical Sciences Stock Signals to Watch This
- KIMS Trading Window Closure Ahead of Q2 FY27 Results
- Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 6% on Wednesday
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.